Papsidero L D, Wang M C, Valenzuela L A, Murphy G P, Chu T M
Cancer Res. 1980 Jul;40(7):2428-32.
A prostate antigen has been detected by a rocket immunoelectrophoresis technique in 17 of 219 sera obtained from patients with advanced prostatic cancer. Sera from 175 patients with nonprostatic cancers, including those with late-stage disease of the breast, lung, colon, rectum, stomach, and pancreas, were antigen negative as were 20 samples each from normal adults and age-matched males. Antigen in sera showed immunological identity with antigen in prostate tissue as determined by immunoprecipitation peak enhancement experiments. Using antibody affinity chromatography and radioimmunoprecipitation techniques, the antigen in sera was purified and subjected to sodium dodecyl sulfate electrophoresis; it exhibited a molecular weight of approximately 36,000, similar to that of antigen isolated from prostatic tissue.
采用火箭免疫电泳技术,在219例晚期前列腺癌患者的血清中,有17例检测到一种前列腺抗原。175例非前列腺癌患者的血清,包括患有乳腺癌、肺癌、结肠癌、直肠癌、胃癌和胰腺癌晚期疾病的患者,均为抗原阴性,正常成年人和年龄匹配男性的各20份样本也呈阴性。通过免疫沉淀峰增强实验确定,血清中的抗原与前列腺组织中的抗原具有免疫同一性。利用抗体亲和层析和放射免疫沉淀技术,对血清中的抗原进行纯化,并进行十二烷基硫酸钠电泳;其分子量约为36,000,与从前列腺组织中分离出的抗原相似。